Drug · DIN 02379074
IPG-RIZATRIPTAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since January 14, 2016.
- Drug Identification Number (DIN)
- 02379074
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 14, 2016: NOC 17667Abbreviated New Drug Submission (ANDS) · Merger - buyout
- January 30, 2012: NOC 12979Abbreviated New Drug Submission (ANDS)
Other DINs named IPG-RIZATRIPTAN
- DIN 02379082 · Approved